Related Experiment Video
Updated: Apr 5, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment
Brittany N Dugger1, Kathryn Davis2, Michael Malek-Ahmadi3
1Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, 10515 W. Santa Fe Dr., Sun City, AZ, 85351, USA. Brittany.dugger@bannerhealth.com.
Background:
Although there are studies investigating the pathologic origins of mild cognitive impairment (MCI), they have revolved around comparisons to normal elderly individuals or those with Alzheimer's disease (AD) or other dementias. There are few studies directly comparing the comprehensive neuropathology of amnestic (aMCI) and nonamnestic (naMCI) MCI.
Methods:
The database of the Brain and Body Donation Program ( www.brainandbodydonationprogram.org ), a longitudinal clinicopathological study of normal aging and neurodegenerative disorders, was queried for subjects who were carrying a diagnosis of aMCI or naMCI at the time of autopsy. Neuropathological lesions, including neuritic plaques, neurofibrillary tangles (NFTs), Lewy bodies (LBs), infarcts, cerebral white matter rarefaction (CWMR), cerebral amyloid angiopathy (CAA), and concurrent major clinicopathological diagnoses, including Parkinson's disease (PD) were analyzed.
Results:
Thirty four subjects with aMCI and 15 naMCI met study criteria. Subjects with aMCI were older at death (88 vs. 83 years of age, p = 0.03). Individuals with naMCI had higher densities of LBs within the temporal lobe (p = 0.04) while subjects with aMCI had a propensity for increased NFTs in parietal and temporal lobes (p values = 0.07). After adjusting for age at death, the only significant difference was greater densities of temporal lobe NFTs within the aMCI group. Other regional pathology scores for plaques, NFTs, and LBs were similar between groups. Subjects met clinico-pathological criteria for co-existent PD in 24 % aMCI and 47 % naMCI while neuropathological criteria for AD were met in equal percentages of aMCI and of naMCI cases (53 %); these proportional differences were not significant (p values > 0.35). Furthermore, regardless of amnestic status, there was a greater presence of CAA (71 % of MCI with executive dysfunction vs. 39 % without p = 0.03) and a greater presence of CWMR (81 % of MCI with executive dysfunction and 54 % without p = 0.046) in MCI cases with executive dysfunction.
Conclusions:
No single pathologic entity strongly dichotomized MCI groups, perhaps due to the pathologic heterogeneity found within both entities. However, these data suggest the possibility for naMCI to have a propensity for increased LBs and aMCI for increased NFTs in select anatomic regions.
Insights
This study compared the neuropathology of amnestic (aMCI) and nonamnestic (naMCI) mild cognitive impairment. While both showed similar overall pathology, naMCI had more Lewy bodies and aMCI had more neurofibrillary tangles in specific brain regions.
Area of Science:
- Neuropathology
- Neurodegenerative Diseases
- Cognitive Impairment
Background:
- Mild cognitive impairment (MCI) research often compares to normal aging or Alzheimer's disease (AD).
- Limited studies directly compare the comprehensive neuropathology of amnestic (aMCI) and nonamnestic (naMCI) MCI.
Purpose of the Study:
- To conduct a comprehensive neuropathological comparison between aMCI and naMCI.
- To identify distinct pathological markers differentiating aMCI and naMCI.
Main Methods:
- Utilized data from the Brain and Body Donation Program, a longitudinal clinicopathological study.
- Analyzed neuropathological lesions including plaques, neurofibrillary tangles (NFTs), Lewy bodies (LBs), infarcts, cerebral white matter rarefaction (CWMR), and cerebral amyloid angiopathy (CAA).
- Assessed concurrent diagnoses such as Parkinson's disease (PD) and AD.
Main Results:
- Compared 34 aMCI and 15 naMCI subjects; aMCI subjects were older at death.
- naMCI cases showed higher temporal lobe Lewy body densities (p=0.04).
- aMCI cases showed a trend towards increased parietal and temporal NFTs (p=0.07), significant after age adjustment.
- Executive dysfunction in MCI correlated with increased CAA and CWMR.
- No significant differences in AD neuropathology; PD co-occurrence differed (24% aMCI vs. 47% naMCI).
Conclusions:
- No single pathology strongly distinguished aMCI and naMCI due to heterogeneity.
- Findings suggest potential regional differences: naMCI may show more Lewy bodies, and aMCI may show more neurofibrillary tangles.
More Related Videos
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amnesia
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Dementia
The progression of dementia is generally gradual....